✦ LIBER ✦

P-550 Phase 1–2 dose-ranging trial of TLK286 (TELCYTA) and Cisplatin (C) as first-line treatment in advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Papadimitrakopoulou, V.; Edelman, M.; Zinner, R.; Blumenschein, G.; Jones, S.; Willcutt, N.; Keck, J.; Brown, G.; Burris, H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-572 Phase I–II trial of TLK286 (telcyt

✍ Seguist, L.; Fidias, P.; Temel, J.; Kennedy, E.; Ostler, P.; Rabin, M.; Huberman 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 328 KB

Phase III trial of docetaxel (D) and car

✍ Giannakakis, Th; Mavroudis, D; Papadouris, S; Kourousis, Ch; Ziras, N; Kakolyris 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 224 KB

Phase II study of Docetaxel and Cisplati

✍ Pawel, J.v.; Faderl, B.; Wagner, H.; Krauβ, C.; Achterrath, W. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Phase II study of Docetaxel and Cisplati

✍ Faderl, B.; von Pawel, J.; Wagner, H.; Krauss, C.; Achterrath, W. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 158 KB

191 Phase II trial of paclitaxel and car

✍ Schütte, W.; Bork, I.; Schädlich, St.; Meyer, M.; Blankenburg, Th. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 166 KB

9149 Phase II study of bevacizumab in co

✍ Ferrer, N.; Cobo, M.; Paredes, A.; Méndez, M.; Muñoz-Langa, J.; Rueda, A.; de Mo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB